147 related articles for article (PubMed ID: 23272094)
1. The pattern of attrition from an antiretroviral treatment program in Nigeria.
Odafe S; Torpey K; Khamofu H; Ogbanufe O; Oladele EA; Kuti O; Adedokun O; Badru T; Okechukwu E; Chabikuli O
PLoS One; 2012; 7(12):e51254. PubMed ID: 23272094
[TBL] [Abstract][Full Text] [Related]
2. Treatment Discontinuation in Adult HIV-Infected Patients on First-Line Antiretroviral Therapy in Nigeria.
Agbaji OO; Abah IO; Falang KD; Ebonyi AO; Musa J; Ugoagwu P; Agaba PA; Sagay AS; Jolayemi T; Okonkwo P; Idoko JA; Kanki PJ
Curr HIV Res; 2015; 13(3):184-92. PubMed ID: 25986369
[TBL] [Abstract][Full Text] [Related]
3. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
[TBL] [Abstract][Full Text] [Related]
4. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
[TBL] [Abstract][Full Text] [Related]
5. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
[TBL] [Abstract][Full Text] [Related]
6. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
[TBL] [Abstract][Full Text] [Related]
7. HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
Saura-Lázaro A; Augusto O; Fernández-Luis S; López-Varela E; Fuente-Soro L; Bila D; Tovela M; Macuacua N; Vaz P; Couto A; Bruno C; Naniche D
AIDS; 2024 Jul; 38(9):1402-1411. PubMed ID: 38652496
[TBL] [Abstract][Full Text] [Related]
8. Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort study.
Ibiloye O; Jwanle P; Masquillier C; Van Belle S; Jaachi E; Amoo O; Isah A; Omole T; Samuel JO; van Olmen J; Lynen L; Okonkwo P; Decroo T
PLoS One; 2021; 16(11):e0260557. PubMed ID: 34847194
[TBL] [Abstract][Full Text] [Related]
9. Patient retention and adherence to antiretrovirals in a large antiretroviral therapy program in Nigeria: a longitudinal analysis for risk factors.
Charurat M; Oyegunle M; Benjamin R; Habib A; Eze E; Ele P; Ibanga I; Ajayi S; Eng M; Mondal P; Gebi U; Iwu E; Etiebet MA; Abimiku A; Dakum P; Farley J; Blattner W
PLoS One; 2010 May; 5(5):e10584. PubMed ID: 20485670
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and early clinical outcomes of key populations attending comprehensive community-based HIV care: Experiences from Nasarawa State, Nigeria.
Ibiloye O; Decroo T; Eyona N; Eze P; Agada P
PLoS One; 2018; 13(12):e0209477. PubMed ID: 30571744
[TBL] [Abstract][Full Text] [Related]
11. Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007-2010.
Mutasa-Apollo T; Shiraishi RW; Takarinda KC; Dzangare J; Mugurungi O; Murungu J; Abdul-Quader A; Woodfill CJ
PLoS One; 2014; 9(1):e86305. PubMed ID: 24489714
[TBL] [Abstract][Full Text] [Related]
12. Long-term survival outcomes of HIV infected children receiving antiretroviral therapy: an observational study from Zambia (2003-2015).
Mutanga JN; Mutembo S; Ezeamama AE; Song X; Fubisha RC; Mutesu-Kapembwa K; Sialondwe D; Simuchembu B; Chinyonga J; Thuma PE; Whalen CC
BMC Public Health; 2019 Jan; 19(1):115. PubMed ID: 30691416
[TBL] [Abstract][Full Text] [Related]
13. Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV "Treat All" in Zimbabwe.
Makurumidze R; Buyze J; Decroo T; Lynen L; de Rooij M; Mataranyika T; Sithole N; Takarinda KC; Apollo T; Hakim J; Van Damme W; Rusakaniko S
PLoS One; 2020; 15(10):e0240865. PubMed ID: 33075094
[TBL] [Abstract][Full Text] [Related]
14. Incidence and predictors of attrition from antiretroviral care among adults in a rural HIV clinic in Coastal Kenya: a retrospective cohort study.
Hassan AS; Mwaringa SM; Ndirangu KK; Sanders EJ; de Wit TF; Berkley JA
BMC Public Health; 2015 May; 15():478. PubMed ID: 25957077
[TBL] [Abstract][Full Text] [Related]
15. Antiretroviral therapy regimen modification rates and associated factors in a cohort of HIV/AIDS patients in Asmara, Eritrea: a 16-year retrospective analysis.
Mengistu ST; Yohannes A; Issaias H; Mesfn M; Zerufael S; Dirar A; Teklemariam HM; Ghebremeskel GG; Achila OO; Basha S
Sci Rep; 2023 Mar; 13(1):4183. PubMed ID: 36918596
[TBL] [Abstract][Full Text] [Related]
16. Implementation and Operational Research: Evaluation of Swaziland's Hub-and-Spoke Model for Decentralizing Access to Antiretroviral Therapy Services.
Auld AF; Kamiru H; Azih C; Baughman AL; Nuwagaba-Biribonwoha H; Ehrenkranz P; Agolory S; Sahabo R; Ellerbrock TV; Okello V; Bicego G
J Acquir Immune Defic Syndr; 2015 May; 69(1):e1-12. PubMed ID: 25942465
[TBL] [Abstract][Full Text] [Related]
17. Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa.
Grimwood A; Fatti G; Mothibi E; Malahlela M; Shea J; Eley B
J Int AIDS Soc; 2012 May; 15(2):17381. PubMed ID: 22713255
[TBL] [Abstract][Full Text] [Related]
18. Treatment outcomes from the largest antiretroviral treatment program in Myanmar (Burma): a cohort analysis of retention after scale-up.
Sabapathy K; Ford N; Chan KN; Kyaw MK; Elema R; Smithuis F; Floyd S
J Acquir Immune Defic Syndr; 2012 Jun; 60(2):e53-62. PubMed ID: 22334069
[TBL] [Abstract][Full Text] [Related]
19. Patients' demographic and clinical characteristics and level of care associated with lost to follow-up and mortality in adult patients on first-line ART in Nigerian hospitals.
Odafe S; Idoko O; Badru T; Aiyenigba B; Suzuki C; Khamofu H; Onyekwena O; Okechukwu E; Torpey K; Chabikuli ON
J Int AIDS Soc; 2012 Sep; 15(2):17424. PubMed ID: 23010378
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
